NSE - Delayed Quote INR

Gland Pharma Limited (GLAND.NS)

1,642.00
+8.40
+(0.51%)
At close: June 6 at 3:30:00 PM GMT+5:30

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
NameTitlePayExercisedYear Born
Mr. Srinivas Sadu Executive Chairman 70.15M -- 1969
Mr. Ravi Shekhar Mitra Chief Financial Officer 20.45M -- 1977
Mr. Sampath Kumar Pallerlamudi Company Secretary & Vice-President of Compliance & CSR 6.05M -- 1981
Mr. Shyamakant Giri Chief Executive Officer -- -- --
Mr. Satnam Singh Loomba Chief Operating Officer -- -- 1968
Mr. Surinder Koul Head of Domestic Marketing -- -- --
Mr. K Raghuramachandra Rao Head of Quality -- -- --
Mr. R.V.R. Prabhakara Sastry Senior Vice President of R&D -- -- --
Mr. Rong Wu Chief Financial Controller -- -- --

Gland Pharma Limited

Plot No. 11 & 84, TSIIC Phase: IV
Pashamylaram (V) Patancheru (M) Sangareddy District
Hyderabad, 502307
India
91 84 5569 9999 https://www.glandpharma.com
Sector: 
Healthcare
Full Time Employees: 
4,286

Description

Gland Pharma Limited engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally. The company engages in research and development of pharmaceutical active pharmaceutical ingredient products, including synthesis of complex drug molecules, such as low molecular weight heparins, corticosteroids, peptides, and cytotoxic molecules. The company offers its products for various therapeutic categories, such as anti-malarial, anti-infectives, anti-neoplastic, blood related, cardiac, gastrointestinal, gynaecological, hormones, neuro/Cns, ophthal/otological, and other areas, as well as pain and analgesics, respiratory, and vitamins, minerals, and nutrients; and contract development services. The company was incorporated in 1978 and is headquartered in Hyderabad, India. Gland Pharma Limited operates as a subsidiary of Fosun Pharma Industrial Pte. Ltd.

Corporate Governance

Gland Pharma Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

August 4, 2025 at 10:59 AM UTC - August 8, 2025 at 12:00 PM UTC

Gland Pharma Limited Earnings Date

August 13, 2025 at 12:00 AM UTC

Ex-Dividend Date

Recent Events

Related Tickers